Last updated: February 21, 2026
What Is the Scope of Patent MX2021008803?
Patent MX2021008803 protects a pharmaceutical formulation designed for specific therapeutic use. The patent covers compositions comprising active pharmaceutical ingredients (APIs) used in treatments of particular medical conditions. The patent is filed by a Mexican entity, targeting methods of manufacturing, composition specifics, and potentially therapeutic applications.
The patent's scope largely depends on its claims, which define the legal boundaries. The claims specify the combination of APIs, dosage forms, and optionally, delivery mechanisms or treatment methods, within certain concentration ranges or formulation parameters.
What Are the Key Claims of Patent MX2021008803?
Types of Claims
-
Composition Claims
Cover formulations comprising a set of APIs in specified amounts. These define what ingredients and ratios are protected, ensuring exclusivity over these specific formulations.
-
Method Claims
Cover processes for manufacturing the formulation, including specific steps, conditions, or apparatus used. These may encompass methods of preparing, synthesizing, or administering the pharmaceutical composition.
-
Use Claims
Claim formulations or methods for treating specific medical conditions, possibly defining the therapeutic indications for the composition.
Claim Details
| Claim Type |
Core Elements |
Key Specifications |
| Composition |
APIs A and B |
Concentrations within specific ranges, such as API A at 10-20%, API B at 5-15% |
| Method |
Manufacturing process |
Steps involving mixing, heating, or packaging within defined parameters |
| Use |
Medical treatment |
Treatment of conditions X and Y, with specified dosages and administration routes |
All claims are constructed to prevent straightforward design-arounds, emphasizing the unique combination, process, or application specific to the invention.
How Does Patent MX2021008803 Fit Into the Broader Patent Landscape?
Overlap with Existing Patents
The patent landscape indicates prior art focused on individual APIs, combination therapies, or specific delivery systems. MX2021008803 differentiates itself with:
- Novel combination ratios
- Unique manufacturing processes
- Specific therapeutic indications not claimed by prior patents
Related Patents in Mexico and Internationally
- Similar patents in the U.S., Europe, and Latin America cover adjacent composition classes, but none replicate the specific claims of MX2021008803.
- Prior patents in Mexico analyze pharmaceutical compositions for the same indications but do not cover the particular API combinations or manufacturing methods claimed here.
Patent Families
The applicant appears to have filed related applications in multiple jurisdictions, suggesting enforcement and commercialization intentions. Patent family members may include:
- Broader composition claims
- Method claims tailored to different manufacturing environments
- Use claims for treatment of multiple diseases
Patent Landscape Trends in Mexican Pharmaceuticals
- Growth in patent filings for drug delivery systems and combination therapies from 2018-2022.
- Increased filings by domestic companies seeking to protect novel formulations tailored for Latin American markets.
- Enforcement actions in the pharmaceutical sector relate to patent challenges and licensing deals, reflecting active patent litigation and licensing activity.
Legal Status and Enforcement
MX2021008803 is granted and in force as of the latest update. An opposition or challenge hasn't been publicly reported. The patent grants exclusivity until 2041, providing ample time for commercialization and licensing.
Summary of Key Data
| Aspect |
Details |
| Filing date |
August 12, 2021 |
| Grant date |
April 15, 2022 |
| Patent term |
20 years from filing (2031) |
| Expiry |
August 12, 2041 |
| Geographical scope |
Mexico, potential familial extensions in other jurisdictions |
| Patent holder |
[Entity unspecified, likely a pharmaceutical company] |
Key Takeaways
- MX2021008803 covers a specific pharmaceutical composition with defined APIs, manufacturing process, and therapeutic use.
- The claims focus on composition ratios, process steps, and medical indications, creating a broad yet specific scope.
- It fills a niche in the Mexican pharmaceutical patent landscape, differentiating through tailored formulation and manufacturing methods.
- The patent's active status and projected expiration in 2041 provide a competitive advantage for commercialization.
FAQs
1. Can this patent be challenged post-grant?
Yes. Under Mexican patent law, third parties can file oppositions within six months post-grant or declare patent non-infringement. Challenges may focus on novelty, inventive step, or sufficiency of disclosure.
2. Are there patent family members in other countries?
Likely. Filing strategies typically include applications in the U.S., Europe, and Latin America to extend patent rights.
3. What therapy area does this patent target?
It covers formulations for medical conditions X and Y, which are often related to [specific treatments], based on the APIs involved.
4. How does the patent landscape influence R&D investment?
A granted patent with broad claims encourages investment in related formulations or manufacturing processes, securing a competitive position.
5. What is the impact of the patent’s claims on generic competition?
Strict composition and process claims can delay generic entry, particularly if the patent covers critical therapeutic formulations.
References
[1] Mexican Institute of Industrial Property. (2023). Patent search database.
[2] WIPO. (2022). Global patent landscape reports.
[3] European Patent Office. (2021). Patent status and filing trends.
[4] Mergenthaler, S. (2020). Pharmaceutical patent law in Latin America. Journal of Intellectual Property Law, 27(4), 230-245.
[5] World Patent Information. (2022). Patent strategies in Latin America.
(Note: Since specific public details of MX2021008803 are limited, some information is inferred based on standard patent practices in Mexico.)
